LLY283，LM-5179

Non Chimik:

(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,3-d]pirimidin-7-yl)-5-[(R)-hydroxy(phenyl)methyl]oxolane-3,4-diol

Kòd SMILES:

O[C@H]1[C@H](N2C=CC3=C(N)N=CN=C32)O[C@H]([C@H](O)C4=CC=CC=C4) [C@H]1O

Kòd InChi:

InChI=1S/C17H18N4O4/c18-15-10-6-7-21(16(10)20-8-19-15)17-13(24)12(23)14(25-17)1 1(22)9-4-2-1-3-5-9/h1-8,11-14,17,22-24H,(H2,18,19,20)/t11-,12+,13- ,14-,17-/m1/s1

InChi kle:

WWOOWAHTEXIWBO-QFRSUPTLSA-N

Mot:

2040291-27-6；CAS:2040291-27-6；CAS:2040291-27-6；LLY-283；LLY 283；LLY283；LM-5179； LM 5179179;

Solibilite:Soluble nan DMSO

Depo:Sèk, nwa ak nan 0 - 4 C pou kout tèm (jou a semèn) oswa -20 C pou tèm long (mwa a ane).

Deskripsyon:

LY-283 se yon inibitè efikas, selektif, ak oral pwoteyin arginine methyltransferase 5 (PRMT5).

Sib: PRMT5